Comanche Biopharma Corp. – Trademark Portfolio
Entity Type: 03
Comanche Biopharma Corp. has 15 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate, with 12 applications currently pending. Filings span 5 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Concord, MA.
50 Beharrell Street, Unit B
Concord, MA 01742
Showing of trademarks Trademarks
Trademark Classifications
Comanche Biopharma Corp.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Comanche Biopharma Corp. have?
Comanche Biopharma Corp. has 15 U.S. trademarks filed with the USPTO. Of these, 3 registered, 12 pending.
What trademark classes does Comanche Biopharma Corp. file in?
Comanche Biopharma Corp. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What is Comanche Biopharma Corp.'s trademark registration success rate?
Comanche Biopharma Corp. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 12 applications are pending review.